Skip to content
Screener

Assembly Biosciences ASMB Q4 2025 Annual earnings

Reported March 19, 2026 · After market close

Revenue$42.5MBeat by $35.0M
EPS$2.48Beat by $2.99
Revenue estimate$7.4M
EPS estimate-$0.51

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$9.1M
EPS estimate-$0.66

Financials

Q4 2025

Income statement

See full
Revenue$42.5M+477%

Balance sheet

See full
Cash & equivalents$58.5M+52.4%
Total debt$2.6M-14.9%
Total equity$206.8M+520%
Total assets$257.6M+116%

Cash flow

See full
CapEx$24.0K—

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$537.94M+436%
Enterprise value$482.12M+641%
P/S7.4×+3.9×

Returns & leverage

See full
Debt / equity0×-0.1×
Current ratio5.2×+2.8×

FAQ

When did Assembly Biosciences report Q4 2025 earnings?
Assembly Biosciences (ASMB) reported Q4 2025 earnings on March 19, 2026 after market close.
What were Assembly Biosciences's Q4 2025 revenue and EPS?
Assembly Biosciences reported revenue of $42.5M and eps of $2.48 for Q4 2025.
Did Assembly Biosciences beat estimates in Q4 2025?
Revenue beat the consensus estimate of $7.4M by $35.0M. EPS beat the consensus estimate of $-0.51 by $2.99.
How did Assembly Biosciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 477.2% from $7.4M a year earlier.
Where can I find Assembly Biosciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-115980) and the 10-K periodic report (0001193125-26-115992) directly on SEC EDGAR. The filing index links above go to sec.gov.